Cardiovascular Endocrinology and Lipid Metabolism

ea0056p292 | Cardiovascular Endocrinology and Lipid Metabolism

Effects of atorvastatin and ezetimibe therapy on LDL Cholesterol. A systematic review and meta-analysis of randomized controlled trial

ea0056p293 | Cardiovascular Endocrinology and Lipid Metabolism

Your patients say they do not tolerate statins? You can still lower their cardiovascular risk with red yeast rice supplementation

ea0056p294 | Cardiovascular Endocrinology and Lipid Metabolism

Lobeglitazone, a novel thiazolidinedione, improves hepatic steatosis in diet-induced obese mice

ea0056p295 | Cardiovascular Endocrinology and Lipid Metabolism

B-type natriuretic peptide: a biomarker of cardiovascular risk in type 2 diabetes.

ea0056p296 | Cardiovascular Endocrinology and Lipid Metabolism

Relationship between the triglyceride glucose index and the presence and fibrosis of nonalcoholic fatty liver disease in Korean adults

ea0056p297 | Cardiovascular Endocrinology and Lipid Metabolism

Adropin concentration correlates with selected anthropometric and biochemical parameters – preliminary report

ea0056p298 | Cardiovascular Endocrinology and Lipid Metabolism

Silent myocardial ischemia in type 2 diabetes patients with ischemic heart disease

ea0056p299 | Cardiovascular Endocrinology and Lipid Metabolism

PCSK9 inhibitors as an add on for the treatment of dislipemia in real clinical practice

ea0056p300 | Cardiovascular Endocrinology and Lipid Metabolism

Treatment adherence through an Integral Care Program for patients with Metabolic Syndrome in Central Mexico

ea0056p301 | Cardiovascular Endocrinology and Lipid Metabolism

Searching the best feeding habits to improve atherogenic dyslipidemia and inflammatory activity in patients with psoriatic arthritis

ea0056p302 | Cardiovascular Endocrinology and Lipid Metabolism

Worse MELD score is linked to a higher rate of metabolic syndrome in HIV/HCV co-infected patients on highly active antiretroviral therapy

ea0056p303 | Cardiovascular Endocrinology and Lipid Metabolism

Improved lipid profile and cardiovascular risk factors after bariatric surgery

ea0056p304 | Cardiovascular Endocrinology and Lipid Metabolism

Efficacy and safety of proprotein convertase subtilisin/kexintype nine inhibitors in real life experience

ea0056p305 | Cardiovascular Endocrinology and Lipid Metabolism

Plasma insulin levels in patients with the different severity of atherosclerotic lesions of coronary arteries

ea0056p306 | Cardiovascular Endocrinology and Lipid Metabolism

A multi-disciplinary approach to the management of NAFLD improves both liver and metabolic health and is cost effective

ea0056p307 | Cardiovascular Endocrinology and Lipid Metabolism

A case of combined dyslipidemia with two different defined genetic alterations

ea0056p308 | Cardiovascular Endocrinology and Lipid Metabolism

Soluble ST2, a promising cardiovascular biomarker, is associated with parameters of glucose and bone metabolism in subjects at cardiovascular risk

ea0056p309 | Cardiovascular Endocrinology and Lipid Metabolism

Comparison of inflamatory parameters, lipid profile and clinical values in patients with clinical and subclinical hypothyroidism

ea0056p310 | Cardiovascular Endocrinology and Lipid Metabolism

Specificity of mathematical indexes versus histopathological findings in the diagnosis of nonalcoholic fatty liver disease in mexican population

ea0056p315 | Cardiovascular Endocrinology and Lipid Metabolism

What changes does pregnancy bring to the lipid parameters of diabetic patients?

ea0056p316 | Cardiovascular Endocrinology and Lipid Metabolism

Endocrine Abstracts

20th European Congress of Endocrinology

Poster Presentations: Diabetes, Obesity and Metabolism

Effects of atorvastatin and ezetimibe therapy on LDL Cholesterol. A systematic review and meta-analysis of randomized controlled trial

Your patients say they do not tolerate statins? You can still lower their cardiovascular risk with red yeast rice supplementation

Lobeglitazone, a novel thiazolidinedione, improves hepatic steatosis in diet-induced obese mice

B-type natriuretic peptide: a biomarker of cardiovascular risk in type 2 diabetes.

Relationship between the triglyceride glucose index and the presence and fibrosis of nonalcoholic fatty liver disease in Korean adults

Adropin concentration correlates with selected anthropometric and biochemical parameters – preliminary report

Silent myocardial ischemia in type 2 diabetes patients with ischemic heart disease

PCSK9 inhibitors as an add on for the treatment of dislipemia in real clinical practice

Treatment adherence through an Integral Care Program for patients with Metabolic Syndrome in Central Mexico

Searching the best feeding habits to improve atherogenic dyslipidemia and inflammatory activity in patients with psoriatic arthritis

Worse MELD score is linked to a higher rate of metabolic syndrome in HIV/HCV co-infected patients on highly active antiretroviral therapy

Improved lipid profile and cardiovascular risk factors after bariatric surgery

Efficacy and safety of proprotein convertase subtilisin/kexintype nine inhibitors in real life experience

Plasma insulin levels in patients with the different severity of atherosclerotic lesions of coronary arteries

A multi-disciplinary approach to the management of NAFLD improves both liver and metabolic health and is cost effective

A case of combined dyslipidemia with two different defined genetic alterations

Soluble ST2, a promising cardiovascular biomarker, is associated with parameters of glucose and bone metabolism in subjects at cardiovascular risk

Comparison of inflamatory parameters, lipid profile and clinical values in patients with clinical and subclinical hypothyroidism

High levels of sclerostin are related to cardiovascular mortality

Lipid profile after pregnancy in women with gestational diabetes mellitus

Secondary diabetes associated with principal endocrinopathies (about 161 cases)

Metabolic syndrome and triglyceride-rich lipoproteins

Specificity of mathematical indexes versus histopathological findings in the diagnosis of nonalcoholic fatty liver disease in mexican population

What changes does pregnancy bring to the lipid parameters of diabetic patients?

Identifying metabolic unhealthy obesity using the product of triglycerides and glucose

BiosciAbstracts